HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
11 - 20 of 189
AAML1921; Bosutinib for Chronic Myeloid Leukemia
The overall goals of this study are to find the best dose of bosutinib that we can give safely, and to find out what effects, good and/or bad, bosutinib has on children and adolescents with Chronic Myeloid Leukemia (CML).
The purpose of this registry is to study the long-term effects and safety of Abatacept(Orencia) as used for the treatment of Juvenile Idiopathic Arthritis(JIA). JIA patients that are currently taking Abatacept may be eligible to participate in this study.
Abemaciclib For Solid Tumors
The purpose of this study is to determine the highest safe dose of abemaciclib in patients with relapsed or treatment refractory solid tumors given in combination with the chemotherapy drugs, irinotecan and temozolomide (Part A) or in combination with just temozolomide (Part B).
ADHD ETA Driving Cohort Study
We are asking both parents and their child between ages 16-18 who recently received their learner's permit to partner with us as we learn more about teen driving safety. We are looking for children both with and without an ADHD diagnosis to participate.
Adolescent Communication of Emotion Study (ACES)
The purpose of this study is to understand how children and adolescents respond to different emotions and social situations.
Allo CD7 CAR WU-CART-007
The purpose of this study is to determine the safety and tolerability of an experimental form of therapy, known as WU-CART-007 (“study drug”).
Alpelisib in PIK3CA-related overgrowth syndrome
The purpose of this study is to find out if alpelisib (BYL719; the “study drug”), is safe and effective (can help) people who have PIK3CA-related overgrowth spectrum (PROS) disease.
ALRN-6924 in Pediatric Cancer
Evaluate the side effects and benefits of ALRN-6924 in patients with relapsed or treatment refractory solid tumor or brain tumor, and to determine the best dose of ALRN-6924 for children and adolescents.
Alterra Adaptive Clinical Trial
The Alterra study is for patients in need of pulmonary valve replacement.
ANBL1232 Response & Biology Risk Factors in Patients with Non-High-Risk Neuroblastoma
In this study we are using new biologic features, in addition to the standard risk factors, to help decide which subjects need treatment and what the best treatment is.